Article
Monoclonal Antibodies in MS
A case of a 19-year-old man being treated with monoclonal antibody therapy for relapsing MS highlights the need for careful monitoring.
Jessica M. Schulte, RN, CCRC, MSCN
A case of a 19-year-old man being treated with monoclonal antibody therapy for relapsing MS highlights the need for careful monitoring.